Future-Ready Clinical Compliance
Future-Ready Clinical Compliance Start the Conversation About Innovation Now AI and other next-generation technologies are poised to reshape clinical research as we know it—especially in
We strive to be your trusted resource for all things clinical compliance. The GCP Compass, our eNewsletter, delivers timely Clinical Compliance News, expert insights, and practical guidance to help you stay ahead in an evolving regulatory landscape. Below is a selection of recent articles—explore more by subscribing to The GCP Compass today.
Future-Ready Clinical Compliance Start the Conversation About Innovation Now AI and other next-generation technologies are poised to reshape clinical research as we know it—especially in
Innovation, Data & Collaboration—The Formula for Progress in Clinical Compliance Authored by Al Pacheco, Director, Business & Technology Consulting, Just in Time GCP I was
Reclaiming Your Trial Master File: A Strategic Move Toward Stronger Clinical Compliance As clinical trial complexity grows and regulatory expectations continue to evolve—particularly with the
Just in Time GCP to Present at CDISC + TMF Europe Interchange 2025 We’re excited to announce that Just in Time GCP will be participating
Proactive GCP Compliance: Insurance for Your Clinical Trial In the world of clinical trials, compliance with Good Clinical Practice (GCP) is often seen as just
Tina Henderson Joins Just in Time GCP to Lead Life Sciences Consulting Just in Time GCP continues to grow, and we are excited to welcome
Implementing Risk-Based Quality Management Insights from the Latest GCP Guide Explore the 2024/2025 Edition of Barnett’s GCP Q&A Reference Guide The 2024/2025 edition of Barnett’s
George Lyon Joins Just in Time GCP to Drive Commercial Growth Just in Time GCP is experiencing rapid expansion, and to sustain our momentum, we
Why the CDISC TMF Reference Model is Important for Smaller Companies Executing Clinical Trials If you’re a small or emerging life sciences company, navigating the
ICH E6(R3) Finalization – An Action Plan for Clinical Compliance Critical Impacts of ICH E6 (R3) and Business Process Updates for Clinical Trial Sponsors The
Hidden TMF Clinical Compliance Risks The Risk Of Inspectable Content Housed Outside the TMF In the fast-paced world of clinical trial compliance, maintaining a robust
20 Years of Clinical Compliance Confidence — And Counting Since 2005, Just in Time GCP has been helping clinical trial teams move forward with clarity,
How Generative AI is Transforming GCP Inspection Readiness Just in Time GCP’s Founder and CEO, Donna Dorozinsky, contributed a guest column for Clinical Leader outlining
Clinical Trial Master File Trends from 2024 As we approach 2025, the Clinical Trial Master File (TMF) landscape is undergoing substantial transformations driven by technological
Just in Time GCP Welcomes George Lyon as Chief Commercial Officer Just in Time GCP is excited to announce the appointment of George Lyon as
Generative AI: Innovating Inspection Readiness and TMF Quality As your partner in clinical trials, we at Just in Time GCP understand the challenges of maintaining
Ensuring Your Operations Support Your Trial’s Scope Moderating a recent roundtable discussion on clinical process assessment has highlighted a growing gap between current clinical process
The Importance of TMF Management in Clinical Quality Just in Time GCP’s Founder and CEO, Donna Dorozinsky, shared her expertise in a recent article in
Just In Time GCP: Recognized for Impact and Innovation in Clinical Research Just In Time GCP is excited to announce our recognition as #9 on
Just in Time GCP is thrilled to announce the appointment of Aaron Grant as the new Head of Innovation, a newly created position designed to
The Just in Time GCP Team At Just in Time GCP (JiT), our team members are integral to our mission of delivering top-tier GCP compliance
Insights from the 2024 Veeva R&D Summit Last week the Just in Time GCP team attended the Veeva R&D Summit in Boston where we proudly
“Processes and Practices Applicable to Bioresearch Monitoring Inspections: Guidance for Industry” is a draft guidance document issued by the FDA in June of this year.
Just in Time GCP, a company focused on enhancing the quality of clinical trials, is proud to announce its inclusion on the 2024 Inc. 5000